− syndrome, characterized by pseudo Pelger-Hü et hypolobulation and small vacuoles in neutrophils, deletion 17p and p53 mutations, have been described in patients with AML and MDS following ET treated with hydroxyurea. 2, 3 We report on a case of AML in an untreated ET patient with structural abnormalities on 17p different from the 17p − syndrome. To our knowledge, this is the first case of AML with 17p rearrangement in a patient with ET previously untreated.
In 1989, a 72-year-old woman was admitted with persistent thrombocytosis (platelet count 632 × 10 9 /l) in the absence of symptoms. According to the criteria of the Polycythemia Vera Study Group a diagnosis of ET was made. 4 No therapy was administered. Ten years later, the patient was evaluated again because of fatigue. Physical examination showed a moderately reduced performance status, pallor and no organomegaly. Leukemic transformation of ET is infrequent. Most of them are related to patients who received cytoreductive treatment during the chronic phase. 5 In contrast, few cases of acute leukemia after untreated ET have been reported and most of them without cytogenetic alterations. 6 The present patient developed AML 10 years after the diagnosis of ET and she had never been treated. No specific mor- phological or immunophenotypic characteristics were present in the case reported here. In fact, she had untreated ET with an acute transformation to AML displaying no typical dysgranulopoiesis of 17p − syndrome in the bone marrow. Interestingly, the patient showed a structural rearrangement of 17p (a duplication at 17p13, demonstrated by Rx-FISH) without involvement of the p53 gene. Nevertheless, conventional cytogenetics and Rx-FISH did not allow the precise identification of the duplicated region from chromosome 17. The case reported illustrates that the acute transformation of ET may also occur in the absence of chemotherapy, as it is well known in other myeloproliferative disorders. 7 Morover, the structural rearrangement on 17p without involvement of the p53 gene did not show the morphological and clinical characteristics of patients with 17p − syndrome.
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